This resolution urges the Food and Drug Administration’s Director to review the safety of all chemical abortion drugs using recent independent studies. It also urges the Director to publicly release a full safety review that includes real-world outcomes and complications.
The resolution asks the FDA Director to conduct and publish a review. It does not itself change access to these drugs or their rules for use.
No publicly available information.
The resolution’s supporters cite concerns about drug safety and say independent research suggests serious complications may be underreported. They call for a review that includes real-world outcomes and complications.
No publicly available information.